Amazon Bio Discovery cut MSK antibody design from a year to weeks, AWS says

Amazon Web Services today launched Amazon Bio Discovery, an application that routes AI-designed antibody candidates directly to DNA Synthesis firm Twist Bioscience and the techbio Ginkgo Bioworks for synthesis and testing, with results flowing back into the same interface that generated them. AWS launched Amazon Bio Discovery with Bayer, the Broad Institute, Memorial Sloan Kettering… The post Amazon Bio Discovery cut MSK antibody design from a year to weeks, AWS says appeared first on Drug Discovery and Development.

Continue reading →